MacDonald Sean Arthur 4
4 · Edesa Biotech, Inc. · Filed Jul 30, 2019
Insider Transaction Report
Form 4
MacDonald Sean Arthur
Director
Transactions
- Award
Common Shares
2019-07-26+786→ 14,369 total
Footnotes (2)
- [F1]Represents additional common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.
- [F2]All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.